Synthetic Biologics Inc (NYSE MKT LLC:SYN)

2.52
Data as of Apr 17
 +0.03 / +1.20%
Today’s Change
0.95
Today|||52-Week Range
3.64
+64.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$144.5M

Company Description

Synthetic Biologics, Inc. operates as a biotechnology company, which is focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. It develops product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. The company's products include reaZin, Trimesta, Effirma and wellZin. Its reaZin product is being developed as a prescription medical food for the dietary management of patients with Alzheimer's disease and mild cognitive impairment. The company's Trimesta is a drug candidate, which is being developed for the treatment of relapsing-remitting multiple sclerosis in women. Its Effirma drug candidate is being developed for the treatment of fibromyalgia. The company was founded by Steven H. Kanzer in January 2001 and is headquartered in Ann Arbor, MI.

Contact Information

Synthetic Biologics, Inc.
617 Detroit Street
Ann Arbor Michigan 48104-1125
P:(734) 332-7800
Investor Relations:
1734332780022

Employees

Shareholders

Mutual fund holders2.99%
Individual stakeholders16.92%
Other institutional11.35%

Top Executives

Jeffrey Lucero RileyPresident, Chief Executive Officer & Director
Charles Even BallantyneChief Financial Officer, Secretary & Treasurer
John James MonahanChief Technology Officer
Michael KalekoSenior Vice President-Research & Development
Andrew BristolVice President-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.